Market Alert: Achillion Pharmaceuticals (NASDAQ:ACHN), Vivint Solar (NYSE:VSLR), LHC Group (NASDAQ:LHCG), Twitter Inc (NYSE:TWTR), Canadian Solar Inc. (NASDAQ:CSIQ)

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced Thursday that it will begin clinical trials with both drugs for Hepatitis-C patients some time in the first half of 2015. These trials will last between six weeks to three months, with results expected in the second half of the year. On Monday shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) closed at $11.06. Company’s EPS growth for next 5 years is recorded as 17.58%.

Vivint Solar, Inc. (NYSE:VSLR) on March 04, 2015, released financial results for the fourth quarter and year ended December 31, 2014. Operating Leases and Incentives Revenue was $5.9 million, up 202% from $1.9 million in the fourth quarter of the prior year. Total revenue for the quarter was $6.9 million, up 248% from $2.0 million in the fourth quarter of the prior year. Vivint Solar, Inc. (NYSE:VSLR) in last trading activity advanced 7.46% to close at $11.52. Company weekly performance is 41.70% while its quarterly performance stands at 24.27%. Vivint Solar, Inc. (NYSE:VSLR) is -38.43% away from its 52 week high.

LHC Group, Inc. (NASDAQ:LHCG)’s currently stock sport a Zacks Rank #1 (Strong Buy). On last trading day LHC Group, Inc. (NASDAQ:LHCG) advanced 0.33% to close at $33.39. Its volatility for the week is 3.58% while volatility for the month is 4.02%. LHCG’s sales growth for past 5 years was 6.80% and its EPS growth for past 5 years was -12.30%. LHC Group, Inc. (NASDAQ:LHCG) monthly performance is 10.82%.

Twitter Inc (NYSE:TWTR) has opened a Hong Kong office, its first in the Greater China region, the company whose microblogging services are blocked on the mainland said on Tuesday. On Monday shares of Twitter Inc (NYSE:TWTR) closed at $47.59. Company’s EPS growth for next 5 years is recorded as 74.90%.

Canadian Solar Inc. (NASDAQ: CSIQ) ON 5 March 2015, announced its financial results for the fourth quarter and full year ended December 31, 2014. Total solar module shipments were 1,125 MW, with 897 MW recognized in revenue, compared to 770 MW recognized in revenue in the third quarter of 2014, and fourth quarter guidance in the range of 810 MW to 860 MW. Net revenue was $956.2 million, compared to $914.4 million in the third quarter of 2014 and fourth quarter guidance in the range of $925 million to $975 million. On Monday shares of Canadian Solar Inc. (NASDAQ:CSIQ) closed at $32.31. Company’s sales growth for last 5 years was 18.60% and EPS growth for next 5 years is recorded as 5.00%.

Leave a Reply

Your email address will not be published. Required fields are marked *

*